CEO of the Electronic Signature Company, ARX, Named to the 2nd Annual PharmaVOICE 100 List

Dr. Gadi Aharoni, CEO of Algorithmic Research (ARX), a leading worldwide provider of digital signatures and data security solutions, has been named as one of the PharmaVOICE 100 Most Inspiring People in the Life Sciences Industry.

"The second annual issue of the PharmaVOICE 100 is dedicated to the unique individuals who have been recognized by the readers of the publication for their positive contributions through leadership, mentoring, and inspiration," says Taren Grom, editor of PharmaVOICE. "Through their actions and passion for the industry, these individuals serve as examples of how one person can make a difference to many."

These 100 men and women are being recognized for their contributions to the life sciences industry and for the positive impact they are having on moving the industry forward.

"I am honored to be included in the PharmaVOICE 100 list," says Dr. Gadi Aharoni, CEO, ARX. "Our effort in building a product that meets the life science's market and deeply enhances the integrity and efficiency of the clinical trial process needs for electronic signatures is bearing fruit, both with sales and in this prestigious industry recognition.

Aharoni adds that regulations such as the FDA’s 21 CFR Part 11, which require the use of proper electronic signatures, have propelled the demand for the legal recognition, and subsequent adoption of electronic signatures. "We have seen, and are continuing to see a growing number of biopharma, medical device manufacturers, clinical research organizations and clinical management organizations adopting our electronic signature solution. This drive is due to their need to ensure legal compliance and to expedite and automate business processes," he says.

Electronic signatures take the concept of traditional paper-based signatures and turn it into an electronic "fingerprint". An authenticated signature “seals” the document, preventing tampering and ensuring integrity and traceability. CoSign provides organizations with a scalable, zero-management turn-key solution that transcends organizational, geographic and technological boundaries.

CoSign® is an electronic signature solution based on standard PKI technology. CoSign guarantees signer authenticity, data integrity, and non-repudiation of electronic documents. With CoSign’s standard electronic signatures, organizations can sign and seal electronic documents, expedite business processes, reduce costs, increase security and comply with regulations.

CoSign electronic signature solution supports all major applications and file formats (Word, Excel, Outlook, PDF, TIFF, AutoCAD, InfoPath and many more). With a rapid deployment, unique centralized approach, built-in integration with an organization's existing user-management directory systems, and extensive third-party application support, CoSign guarantees a quick ROI.

More information about CoSign is available here

About Algorithmic Research (ARX)

Algorithmic Research (ARX) is a leading global provider of electronic-signature and data-security solutions. The company offers a wide range of high-end and state-of-the-art products and services designed to simplify, secure, and accelerate electronic transactions. ARX specializes in designing and implementing easy to use, simple to deploy, electronic signature and security solutions, combining software and hardware products, for small, medium and large computing environments.

ARX has more than 18 years of experience in assisting financial institutions, governmental organizations and commercial sectors to secure and streamline their processes and transactions. In the life sciences market, ARX clients include biopharmaceutical, medical device, and nutritional companies, contract research organizations (CROs), hospitals and clinics, central laboratories, and contract service organizations and software vendors proving clinical trial focused solutions, electronic medical records systems, and imaging systems. CoSign is deployed in applications regulated by FDA 21 CFR Part 11 for Electronic Records and Signatures. ARX is a member of the SAFE BioPharma partner program www.safe-biopharma.org. Additional information about ARX Life Science practice is available at www.arx.com/industries/lifesciences.php.